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Abstract
Exposure to high levels of fluoride during tooth development will lead to 
mineralization defects and a decrease in enamel strength, known as enamel fluorosis. It has
been proposed that fluoride may alter the cytoskeleton of ameloblasts, cells that secrete 
enamel during tooth development. This change is carried out through the Rho pathway, more
specifically through RhoA. RhoA is stimulated by Wnt3a, a part of the Wnt pathway
involved in regulation of cell proliferation and differentiation. The main component of the
Wnt pathway, β-catenin, is expressed in dental epithelium and acts by linking cadherins to 
the actin cytoskeleton in cell adhesion.
This study examined the effect of sodium fluoride on the Wnt and Rho pathways in 
ameloblast-lineage cells (ALC) from a mouse animal model. ALC were treated with Dkk-1 
and sFRP-2, extracellular receptor inhibitors of the Wnt pathway. Treatment with β-catenin­
siRNA was used as an intracellular inhibitor of Wnt, while RhoADN plasmid and Y-27632 
were added to inhibit RhoA and Rho-associated protein kinase (ROCK) pathway
components, respectively. Following treatment with inhibitors and 1.5 mM NaF, cells were
analyzed via Rho pulldown assay, immunoprecipitation, Western blot, Topflash luciferase
assay, and alkaline phosphatase assay. 
Western blot and Topflash luciferase assay results verified that both the Wnt and Rho
pathways were up-regulated by NaF. Wnt was discovered to be located upstream from the
Rho pathway as confirmed by treatment with Wnt pathway cell receptor inhibitors, Dkk-1 
and sFRP-2, leading to a decrease in RhoA and ROCK activity. Inhibition of the Rho
pathway with RhoADN plasmid and Y-27632 caused up-regulation of Wnt pathway activity, 
  
v 
which was found to negatively regulate ALC differentiation. These data suggest that the
crosstalk between these pathways could lead to the development of enamel fluorosis.  
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Introduction
1.1 General Description of Teeth
The importance of oral health is often underestimated. Improper dental care can lead 
to numerous oral diseases and cause problems with overall health. Teeth are essential for
many functions including mastication, speaking and aesthetics (Nanci, 2008). The structure
of our teeth provides for these functions and if treated properly, they will last throughout our
lifespan. 
Each tooth contains four main components: enamel, dentin, pulp, and root. The outer
surface of the tooth is covered with enamel, a hard, acellular, mineralized substance formed 
by epithelial cells (Nanci, 2008). Enamel is the most mineralized tissue in the human body
due to a high ratio of inorganic hydroxyapatite mineral to organic material and water (Nanci, 
2008). The composition, orientation, disposition and morphology of the mineral determine
the physical and physiological properties of enamel (Mahoney et al., 2004). The organic
matrix of enamel is composed of structural proteins and enzymes. A majority of enamel
proteins are composed of amino acid residues including proline, leucine, glutamine, and 
histidine (Termine et al., 1980). As a group, these proteins are referred to as amelogenin 
(Eastoe, 1979), a critical component in structural formation and enamel mineralization 
(Matsuzawa et al., 2009). The cells that produce enamel, ameloblasts, are lost once the
maturing tooth erupts into the oral cavity, making regeneration of enamel impossible (Nanci, 
2008). Amelogenin makes up over 90% of the proteins that are secreted by ameloblasts
(Aoba and Fejerskov, 2002). When the amelogenin gene is mutated or absent, teeth can be
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hypomineralized (Gibson et al., 2001), which demonstrates the importance of structural
proteins in proper enamel formation. Although the major function of amelogenin is to 
provide structural support to growing mineral crystals, some amelogenins were recently
suggested to have a role in cell signaling (Matsuzawa et al., 2009).
1.2 The Effects of Fluoride and Enamel Fluorosis
Since enamel cannot be replenished, proper treatment is imperative. Dietary fluoride
is known for preventing dental caries or tooth decay (Wong et al., 2011), and acts by
inhibiting enamel demineralization and enhancing remineralization. The incorporation of
fluoride, either topically or systemically, into hydroxyapatite mineral stabilizes the enamel
crystal structure (Hargreaves, 1992) to control the progression of dental caries. Fluoride has
been the most effective treatment for the prevention of caries since the 1940s (Wong et al., 
2011), due to the initiation of water fluoridation. A lower rate of caries development is seen 
in communities with fluoridated water (Newbrun, 2010). Optimal levels of fluoride in 
drinking water maximize its anticaries properties while minimizing the effect of fluorosis
(Centers for Disease Control and Prevention, 2011). 
While fluoride consumed in proper amounts is used to prevent and control tooth 
decay, it has contradictory effects on ameloblast cells. High intake of fluoride has been 
associated with changes in dentin, cementum, bone, and enamel (Aoba and Fejerskov, 2002), 
the most sensitive of the mineralized tissues (Robinson et al., 2004). When consumed in 
excess during amelogenesis, the process of enamel formation during tooth development,
fluoride may cause changes in the enamel rod size, number, shape and quality of interaction 
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to form a strong web-like structure (Eanes and Hailer, 1998). This exposure will lead to a
developmental disturbance of dental enamel known as enamel fluorosis (Alvarez et al., 
2009). The critical period for fluoride overexposure includes the child’s development in utero 
up to age 4 (Alvarez et al., 2009), but children can be at risk until the age of 8 (Centers for
Disease Control and Prevention, 2011) or until the secondary teeth erupt from the gums. 
The degree of enamel fluorosis is directly related to excessive amounts of fluoride
intake (Newbrun, 2010); however, the individual’s response, weight, physical activity, 
nutrition, and length of overexposure can have an effect on the severity (Alvarez et al., 
2009). Enamel structural changes include increased organic content, porosity (Alvarez et al., 
2009; Denbesten, Crenshaw, and Wilson, 1985), and decreased mineral content (Denbesten, 
Crenshaw, and Wilson, 1985) leading to higher susceptibility of caries development. Enamel
fluorosis causes a range of effects including opaque striations, porous deterioration of
enamel, yellow discoloration and a mottled appearance. Mild dental fluorosis is characterized 
by bilateral, diffuse, opaque white striations that run horizontally across the tooth (Alvarez et
al., 2009). In more severe cases, the enamel pitting and porous regions increase in size, and 
discoloration of the enamel surface is seen (Bronckers, Lyaruu, and DenBesten, 2009)
(Figure 1). 
 
 
 
 
     
 
   
 
 
  
  
    
   
   
      
 
  
    
4
Figure 1: Various Grades of Enamel Fluorosis in comparison to Normal Dentition. (A) 
normal teeth; (B) mild dental fluorosis; (C) moderate dental fluorosis; (D) severe dental 
fluorosis (Centers for Disease Control and Prevention, 2011). 
According to the Centers for Disease Control and Prevention (CDC), almost all
naturally occurring water sources contain fluoride. However, communities with low levels of
natural fluoride in their municipal water source may decide to supplement the level of
fluoride. The United States Environmental Protection Agency (EPA) has determined an 
enforceable maximum contaminant level (MCL) for fluoride in drinking water of 4.0 mg/L
(4.0 ppm) to prevent possible health issues. The secondary standard maximum contaminant
level (SMCL) is 2.0 mg/L (2.0 ppm), and is a non-enforceable guideline for levels of fluoride
in drinking water to prevent cosmetic and aesthetic effects (Environmental Protection 
Agency, 2010). Although the SMCL is unenforced, it is recommended by the EPA and states
may choose to take on these levels as enforced standards. 
 
 
  
   
   
    
   
  
 
  
 
 
    
    
   
   
   
 
 
  
 
   
  
5
Along with fluoridated water, there are four other sources that may increase the risk 
for enamel fluorosis. These are fluoridated toothpastes, mouth rinses, fluoride supplements
and lastly, gel, foam and varnish fluoride treatments which are professionally applied 
(Alvarez et al., 2009; Centers for Disease Control and Prevention, 2011). It is necessary for
dental professionals and parents to put effort into monitoring and controlling the fluoride
intake of their patients and children, as this is the best preventative measure against enamel
fluorosis.
1.3 Cell Signaling in the Development of Teeth and Enamel Fluorosis
There are several theories on the developmental mechanisms of enamel fluorosis. 
Fluoride is likely to have multiple effects on enamel, including altered protein/mineral 
interactions as well as a direct effect on ameloblasts (Yan et al., 2007). Li et al. (2005)
proposed that fluoride may alter the cytoskeleton of ameloblasts through a member of the
Rho pathway, RhoA. The Rho pathway is composed of a family of GTPases that regulate the 
formation of actin stress fibers (Ridley, 1996). The Rho family plays a significant role in 
many cell functions including motility, vesicle trafficking, progression through the cell cycle,
differentiation, gene transcription and apoptosis (Biz et al., 2010). RhoA is recognized as a 
molecular switch that normally cycles from the active GTP-bound form to the inactive GDP-
bound form, and regulates downstream events leading to structural changes in the
cytoskeleton (Li et al., 2005). 
Treatment with sodium fluoride affects the RhoA pathway, which is expressed in 
ameloblasts during tooth development (Li et al., 2005). Rho-mediated signaling has a 
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potential influential role in amelogenesis (Biz et al., 2010; Hatakeyama et al., 2009). RhoA
interacts with proteins that regulate cell growth and mitogenesis (Ridley, 1996). Rho signals
are passed along to its downstream effectors, which include ROCK (Rho-associated protein 
kinase) (Otsu et al., 2010). The ROCK family of kinases assists in Rho-induced formation of
focal adhesions and actin stress fibers (Ishizaki et al., 2000).
Previous studies have shown that RhoA is stimulated by Wnt3a (Rossol-Allison et al., 
2009), a member of the canonical Wnt pathway involved in regulation of cell proliferation 
and differentiation (Nelson and Nusse, 2004). Recent advances in oral research have revealed 
essential roles for Wnt signaling in the development of many tissues (Liu and Millar, 2010)
including teeth, which have been demonstrated in mouse and human studies (Dassule and 
McMahon, 1998). The relationship between Rho and Wnt signaling can be seen through their
roles in tooth development; they are parallel pathways (Rossol-Allison et al., 2009) and there 
appears to be crosstalk between them. 
The nineteen Wnt family members found so far have been divided into two pathways, 
the non-canonical and canonical, based on their efficiency in activating the Wnt pathway
(Liu and Millar, 2010). Although the non-canonical pathway is less understood, it appears to 
be independent of β-catenin (Eisenmann, 2005), the main component of the canonical Wnt
pathway. β-catenin is a transcriptional cofactor that activates specific target genes involved in 
different processes along with T-cell factor/lymphoid enhancer factor (TCF/LEF) (Nelson 
and Nusse, 2004). β-catenin is expressed in dental epithelium and acts by linking cadherins to 
the actin cytoskeleton in the process of cell adhesion (Nelson and Nusse, 2004). 
In the absence of Wnt signaling, β-catenin associates with the inhibition complex
composed of adenomatous polyposis coli (APC) and axin proteins, and is phosphorylated by
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glycogen synthase kinase 3β (GSK3β) and casein kinase Iα (CKIα) at its N-terminal 
degradation box (Liu and Millar, 2010). Phosphorylated β-catenin is ubiquitinated and 
degraded by the proteosome (Eisenmann, 2005) (Figure 2A). TCF/LEF can bind to DNA
and other factors to suppress transcription (Eisenmann, 2005).
Activation of the canonical Wnt pathway occurs when Wnt binds two receptor
molecules, frizzled protein and lipoprotein receptor related protein 5 and 6 (LRP 5/6) (Nelson 
and Nusse, 2004). Upon interaction, Frizzled phosphorylates the cytoplasmic protein 
Disheveled (DSH) with CKIα and causes its binding to GSK3β (Liu and Millar, 2010). These
interactions inactivate the Axin/APC/GSK3β/CKIα complex, which stabilizes cytoplasmic-β­
catenin (Liu and Millar, 2010). Stabilization and accumulation of β-catenin lead to nuclear
translocation and interaction with TCF/LEF family transcription factors (Eisenmann, 2005)
(Figure 2B), which leads to up-regulated target gene expression.
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Figure 2: The Canonical Wnt Signaling Pathway. (A) Lack of Wnt signal causes
phosphorylation and ubiquitination of β-catenin by the inhibition complex
(Axin/APC/GSK3β/CKIα). (B) Binding of Wnt to cell receptors LRP 5/6 and Frizzled leads
to inactivation of the inhibition complex. β-catenin is allowed to stabilize and accumulate in 
the cytoplasm before translocation to the nucleus to activate transcription (Eisenmann, 2005).
1.4 Relationship between the Wnt and Rho Pathways
Several studies have shown a correlation between the Wnt and Rho signaling
pathways. Rossol-Allison et al. (2009) suggested that RhoA activation does not directly
affect β-catenin stabilization and accumulation, but is known as a “positive modifier” that
acts parallel to the Wnt pathway. Esufali and Bapat (2004) stated that activated RhoA
 
 
    
 
   
    
  
 
  
   
    
  
     
    
 
9
contributes to the signaling activity of β-catenin by promoting its accumulation in the nucleus
and subsequent transcription.
In the present study, I explored the relationship between the Wnt and Rho pathways
in an ameloblast-lineage cell (ALC) line isolated from developing tooth germs mandibular
molars (Nakata et al, 2003). Inhibition of extracellular Wnt receptors, LRP 5/6 and Frizzled, 
was carried out using two inhibitors, Dickkopf-related protein 1 (Dkk-1) and secreted 
frizzled-related protein 2 (sFRP-2), respectively. Silencing RNA (siRNA) was used to inhibit 
the intracellular Wnt transcriptional factor β-catenin by knocking down gene expression. 
Inhibition of the Rho pathway was carried out by transfection with a RhoADN (dominant
negative) plasmid. Lastly, Y-27632 is a selective inhibitor of ROCK and acts by competing
with the kinase for binding to ATP (Ishizaki et al., 2000). Figure 3 shows a schematic of the
respective inhibitors, where they act in the pathways, and possible crosstalk signaling.
 
 
 
 
     
  
 
     
   
 
   
 
 
 
 
 
 
10
Figure 3: Diagram of the crosstalk between the Wnt and Rho pathways. The Wnt
pathway is activated by binding to receptors LRP5/6 and Frizzled, which can then lead to 
activation of the Rho pathway. Fluoride stimulates signals to β-catenin and Rho factors, 
RhoA and ROCK. β-catenin accumulation in the cytoplasm leads to nuclear translocation. In 
addition, RhoA sends signals to ROCK, which causes β-catenin induction of target genes in 
the nucleus. In this experiment, inhibitors Dkk-1 and sFRP-2 were used to block Wnt cellular
receptors LRP5/6 and Frizzled. β-catenin-siRNA was used to down-regulate β-catenin, and 
RhoADN and Y-27632 were used to block RhoA and ROCK, respectively. Dashed lines
signify possible interaction between proteins examined in the present study.
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1.5 Aim of the Study/Hypotheses
The aim of this project was to increase the knowledge about interactions between the
Wnt and Rho pathways in respect to how they are each affected by fluoride. This
investigation aims to provide a better understanding of the mechanisms involved in sodium
fluoride induced cell signaling transduction. 
Hypotheses:
1.	 Sodium fluoride triggers the canonical Wnt pathway through Frizzled and LRP5/6 
receptors.
2.	 Wnt signaling and β-catenin are upstream of and can control Rho pathway signaling.
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Materials & Methods
2.1 Reagents
Antibodies: Anti-RhoA, anti-β-catenin, and anti-GAPDH were ordered from Cell Signaling
Technology (Boston, MA, USA). Anti-ROCK II was purchased from Santa Cruz
Biotechnology (Santa Cruz, CA, USA), and anti-Lamin B1 from Abcam Inc. (Cambridge, 
MA, USA). Anti-phospho-MYPT1 was purchased from Millipore (Billerica, MA, USA).
Inhibitors: Recombinant Mouse Secreted Frizzled Related Protein-2 (sFRP-2) and 
Recombinant Mouse Dickkopf Related Protein-1 (Dkk-1) were purchased from R&D
Systems (Minneapolis, MN, USA). In-Solution Y-27632 was purchased from Calbiochem
(La Jolla, CA, USA). β-catenin siRNA (m), Control siRNA-A, and siRNA Transfection 
Reagent were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA).
2.2 Cell Culture
Ameloblast-Lineage Cells (ALC) cultivated from a wild type (WT) mouse model 
(Nakata et al., 2003) were grown in minimum essential medium (MEM) supplemented with 
10% fetal bovine serum, 1% Penicillin-Streptomysin , 1% L-glutamine, 0.2 mM calcium
chloride, and 10 ng/ml recombinant human epidermal growth factor (Sigma-Aldrich, St. 
Louis, MO, USA). Trypsin (10% in PBS) was used to passage the cells as needed. Medium
 
 
   
 
 
  
 
  
  
 
    
  
 
 
  
 
   
 
 
  
  
   
  
 
13
was changed every other day, and fresh L-glutamine (1% of current medium volume) was
added to medium weekly.
2.3 Transformation of Plasmid DNA into E.coli
Plasmid (1 µg RhoADN, pcDNA3, Topflash, and Fopflash; 20 µg pRL-SV40) was
used to transform E. coli DH5α competent cells. The tubes containing E. coli and DNA were
placed in a water bath at 42 °C for a 40 second heat shock, and then placed on ice for 3 
minutes. Three hundred µl of Super Optimal broth (SOC) was added prior to shaking in 
incubator for one hour at 37 °C. The resulting solution was streaked across an LB agar plate
containing the appropriate antibiotic (Ampicillin, 100 µg/ml) and incubated at 37 °C
overnight.
2.4 Plasmid DNA Purification
A single colony from the bacterial plate was picked to inoculate 100 ml LB medium
containing antibiotic (100 µg/ml) and grown overnight in a New Brunswick Innova 4300 
incubator at 37 °C with vigorous shaking (300 rpm). Following incubation, the bacterial cells
were harvested by centrifugation at 6000 x g for 15 minutes at 4 °C. The plasmid DNA was
purified following the Plasmid Purification protocol recommended by the manufacturer
(Qiagen, Valencia, CA, USA). In addition, bacteria were reserved and stored in 30% glycerol
at -80 °C. 
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2.5 Treatment with Wnt Receptor Inhibitors
ALC were plated into five 60 mm plates labeled: Control, sodium fluoride (NaF), 
NaF + Dkk-1, NaF + sFRP-2, and both inhibitors (NaF + Dkk-1 + sFRP-2). Once cells were 
grown to 70-80% confluence, 0.1 µg/ml Dkk-1 and 0.15 µg/ml sFRP-2 were added to their
respective groups. Six hours following inhibitor treatment, sodium fluoride was added to a
final concentration of 1.5 mM. Samples were collected four and eight hours following
addition of sodium fluoride.
2.6	 Treatment with Rho Pathway and β-catenin Inhibitors
The ALC were separated into two groups based on the inhibitors used in treatment:
1.	 Rho pathway inhibitors – Control, NaF, NaF + pcDNA3, NaF + RhoADN, NaF + 
Y-27632
2.	 Wnt pathway inhibitors – Control, NaF, NaF + Control siRNA-A, NaF + β­
catenin-siRNA
ALC were grown to 70-80% confluence. Firstly, 4 µg pcDNA3 and RhoADN were 
transfected using 10 µl Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA) in Opti-MEM 
(Invitrogen). Medium was replaced with fresh medium containing 10% serum 6 hours after
treatment.
Simultaneously, 6.5 µl control siRNA-A (designated si-C in figures) (Santa Cruz
Biotechnology, Santa Cruz, CA, USA) and 6.5 µl β-catenin siRNA (designated si-S in 
figures) (Santa Cruz Biotechnology) were transfected into cells with siRNA Transfection 
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Reagent (Santa Cruz Biotechnology) in 1 ml siRNA Transfection Medium (Santa Cruz
Biotechnology). After 6 hours of treatment, 1 ml of 4X medium was added to wells.
Twenty-four hours after treatment of RhoADN, 10 mM In-Solution Y-27632 
(Calbiochem, La Jolla, CA, USA), a selective inhibitor of Rho-Associated protein kinase
(ROCK), was added to ROCK inhibited groups. Six hours later, 1.5 mM sodium fluoride was
added to all groups except the controls. Samples were collected at different time intervals
depending on the following analysis.
2.7 Sample Collection
ALC samples were washed twice with PBS and collected in PBS, volume in ml 
dependent on size of vessel. Cells were scraped, removed, and placed into an empty 15 ml
centrifuge tube. The samples were centrifuged for 5 minutes at 1500 rpm (Clay Adams
Dynac Centrifuge, Becton Dickinson, Sparks, MD, USA). Excess PBS was removed. Cell
pellet was diluted in 300 µl cell lysis buffer and transferred to a 1.5 ml centrifuge tube. ALC
pellet was vortexed and centrifuged at 14,000 x g in room temperature before measurement
of the protein concentration. 
2.7.1 Protein Concentration Assay
Protein standard curves were generated using a 20 µg/ml solution of BSA. Unknown 
concentrations of cell lysates were measured using the Bradford protein assay by optical
 
 
  
 
 
  
 
   
 
  
  
  
   
  
 
   
 
  
   
  
 
  
 
  
 
16
density at 595 nm on a Beckman Coulter DU 730 UV/Vis Spectrophotometer. Cell extracts
were diluted to maintain an equal concentration.
2.7.2 Rho Pulldown Assay for Activated Rho 
Fifteen µl of Rho Assay Reagent slurry (Millipore, Billerica, MA, USA) was added to 
each cell extract centrifuge tube. The reaction mixtures were incubated for 45 minutes at 4° C
with gentle agitation followed by brief centrifugation (10 seconds, 14,000 x g, 4 ˚ C). 
Supernatant was removed and discarded and the remaining beads were washed three times
with 0.5 ml 5X Mg2+ Lysis/Wash Buffer (MLB) (Millipore). After removal of the third wash 
of MLB, the amount of solution was brought up to 20 µl with fresh MLB and 6 µl 4X
loading buffer was added to the beads. The samples were boiled and run on SDS-PAGE.
2.7.3 Immunoprecipitation for Activated ROCK
For each sample, 20 µl of agarose-protein G beads (Santa Cruz Biotechnology) was
diluted into 200 µl of radio-immunoprecipitation assay (RIPA) buffer. One hundred µg of
diluted protein G beads was added to each cell lysate. Cell samples were placed on a shaker
in 4 ˚C for 10 minutes and immediately centrifuged for 20 seconds at 3000 rpm (~734 x g). 
Supernatant was transferred to a new tube and 0.5 µl ROCK-II (Santa Cruz Biotechnology)
was added. Samples were rotated for 30 minutes at 4 ˚C. The remaining 100 µl of protein G
beads was added to each tube, rotated for 15 minutes, and immediately centrifuged for 20 
seconds at 3000 rpm. Supernatant was discarded. 
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To the immunoprecipitated ROCK beads, 20 µl of lysis buffer, 1.5 µl of 100 µM ATP
and 0.5 µl rMYTP1 was added so total volume in each tube was < 25 µl. Sample tubes were 
incubated in New Brunswick Innova 4300 bacterial shaker (300 rpm) at 37 ˚C for 30 
minutes. Samples were boiled and run on SDS-PAGE.
2.8 Western Blot
Thirty µg of each protein was loaded in pre-cast 4-20% precise protein gels (Thermo 
Fisher Scientific, Rockford, IL, USA). Following electrophoresis, the gels were transferred to 
polyvinylidene fluoride (PVDF) membranes using 300 mA for two hours. Membranes were
blocked with 5% nonfat milk for two hours at room temperature and were incubated with 
primary antibodies at 4 ˚C overnight. The membranes were then rinsed and incubated with 
HRP-conjugated secondary antibodies (1:5000 dilution) at room temperature for two hours. 
Immunoreactive proteins were visualized by incubation with SuperSignal West Femto 
Thermo Maximum Sensitivity Substrate (Thermo Fisher Scientific). 
Membranes were incubated with the following antibodies to identify proteins of
interest: anti-RhoA, anti-β-catenin, (1:1000, Cell Signaling Technology, Boston, MA, USA), 
anti-ROCK II (1:1000, Santa Cruz Biotechnology), anti-Lamin B1 (1:1000, Abcam Inc., 
Cambridge, MA, USA), anti-phospho-MYPT1 (Thr850) (1:1000, Millipore), and anti-
GAPDH (1:1000, Cell Signaling Technology, Boston, MA, USA).
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2.9 Topflash Luciferase Assay
ALC seeded in four 12-well plates were treated following the protocol for ALC
treatment with Rho and Wnt pathway inhibitors. Adherent cells were co-transfected with 
Topflash firefly reporter plasmid (or Fopflash, which contains a mutated TCF binding site
and acts as a negative control) to measure β-catenin transcriptional activity and pRL-SV40 
Renilla plasmid. Both Topflash and Fopflash cell groups were collected at 4 and 8 hours
following addition of sodium fluoride. 150 µl 1X Passive Lysis Buffer (Promega, Madison, 
WI, USA) was added to cell plated wells, and the plate was gently shaken for 15 minutes at
room temperature. The lysates were then transferred to a 1.5 ml centrifuge tube.
The cell lysates were diluted to equal concentrations following Bradford protein 
concentration assay. Cell lysates were added to a 96-well plate. Dual-Luciferase Reporter
Assay protocol was followed as recommended by the manufacturer (Promega) and samples
were read using a Labsystems Luminoskan Ascent Microplate Reader (Waltham, MA, USA). 
2.10 Alkaline Phosphatase Assay
ALC seeded into four 6-well plates were treated following the protocol for ALC
treatment with Rho and Wnt pathway inhibitors. After 48 and 72 hours in culture following
treatment with sodium fluoride ALC were washed twice with ice cold PBS. Once wash 
solutions were aspirated the cells were lysed with 0.6 ml Cell Lysis Buffer (Cell Biolabs, 
Inc., San Diego, CA, USA). After a 10 minute incubation at 4 ˚C the ALC solution was
removed and centrifuged (12,000 x g for 10 minutes). The supernatant was removed and used 
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as the cell lysate. A standard curve was run in parallel for comparison. Cell lysates were 
transferred to a 96-well plate and were processed for ALP activity using StemTAG Alkaline
Phosphatase Activity Assay Kit (Colormetric) (Cell Biolabs, Inc.). Using a Dynatech 
Laboratories MRX Microplate Reader, absorbance of each well was read at 405 nm.
2.11 Statistics
All data is reported as means ± SD. Statistical significance was assessed using
analysis of variance (ANOVA). Post-hoc analysis was carried out using a Student-Newman-
Keuls test and Holm-Sidak test. Significance was defined as P < 0.05.
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Results
3.1 Inhibition of the Rho Pathway via Wnt Cell Receptor Inhibitors, Dkk-1 and sFRP-2
ALC treated with Wnt signal antagonists and NaF were analyzed using a Rho 
pulldown assay, immunoprecipitation for activity of ROCK, and Western blot. Samples were
collected 4 hours following treatment with 1.5 mM sodium fluoride. 
In order to confirm the efficiency of the Wnt cell receptor inhibitors Dkk-1 and sFRP­
2, the levels of cytoplasmic and nuclear-β-catenin were analyzed. Treatment with sodium
fluoride led to high activity of both cytoplasmic and nuclear-β-catenin. This up-regulation of
β-catenin could have happened through the conventional receptors, LRP5/6 and Frizzled. 
Treatment with both of the Wnt cell receptor antagonists inhibited the Wnt signal, as
demonstrated  by a significant decrease in accumulation of cytoplasmic-β-catenin and 
nuclear-β-catenin, which each had a P value < 0.05 (Figure 4A). Although a decrease in 
activity was seen, nuclear-β-catenin was not as susceptible to the inhibition as cytoplasmic-β­
catenin (Figure 4B).
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Figure 4: Cytoplasmic-β-catenin and Nuclear-β-catenin Levels with Treatment of Wnt
Cell Receptor Inhibitors, Dkk-1 and sFRP-2. (A) Western blot showing the levels of
cytoplasmic-β-catenin and nuclear-β-catenin. Cytoplasmic-β-catenin was normalized with 
GAPDH and nuclear-β-catenin was normalized with Lamin B1. (Lane C, control; lane F, 
NaF; lane FD, NaF + Dkk-1; lane FS, NaF + sFRP-2; lane FDS, NaF, Dkk-1 + sFRP-2). (B) 
Normalized band intensity of cytoplasmic-β-catenin and nuclear-β-catenin. Cytoplasmic-β­
catenin significantly decreased with all inhibitor groups and nuclear-β-catenin decreased 
significantly in the FDS treated group (*P < 0.001, **P < 0.05). 
RhoA and ROCK activity showed a similar trend. Rho pulldown and 
immunoprecipitation assays showed that sodium fluoride significantly up-regulates activity
of the Rho pathway components, RhoA and ROCK (Figure 5); both results were statistically
significant (P < 0.01) compared to all other treatment groups. However, treatment with Wnt
pathway cell receptor inhibitors Dkk-1 and/or sFRP-2 caused a decrease in RhoA and ROCK
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activity (Figure 5B). The greatest decrease in activity was seen when both Dkk-1 and sFRP­
2 were used together. 
Figure 5: RhoA and ROCK Activities are Down-regulated by Treatment with Wnt 
Pathway Cell Receptor Inhibitors, Dkk-1 and sFRP-2. (A) Western blot showing
activated RhoA and ROCK. Activated RhoA was normalized with total RhoA and activated 
ROCK, measured by phosphorylated MYPT-1, was normalized with total ROCK. (Lane C, 
control; lane F, NaF; lane FD, NaF + Dkk-1; lane FS, NaF + sFRP-2; lane FDS, NaF, Dkk-1 
+ sFRP-2). (B) Normalized band intensity of activated RhoA and ROCK. RhoA and ROCK
activity both significantly increase with treatment of sodium fluoride (P < 0.01) in 
comparison to all treatment groups. A decrease in RhoA and ROCK activity is observed with 
treatment of receptor inhibitors Dkk-1 and sFRP-2. 
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3.2 Inhibition with β-catenin siRNA Down-regulates the Rho Pathway and ALP Activity
ALC treated with control siRNA and β-catenin-siRNA confirmed that the addition of
β-catenin-siRNA down-regulates the Wnt pathway. Transfection of β-catenin-siRNA did not
yield a significant increase in luciferase activity compared to the Topflash control (group C) 
(Figure 6). Cells treated with β-catenin-siRNA show a significant decrease in Topflash 
activity (P < 0.05) in comparison to sodium fluoride and control siRNA treated groups.
Figure 6: Topflash Activity for β-catenin-siRNA Treated Groups. Sodium fluoride + β­
catenin-siRNA down-regulates Wnt pathway activity (P < 0.05) in comparison to sodium
fluoride and control siRNA treated groups. (C = Control; F = NaF; F + si-C = NaF + control
siRNA; F + si-S = NaF + β-catenin-siRNA).
With verification that siRNA down-regulates the Wnt pathway, a Western blot was
run for siRNA samples and incubated with RhoA antibodies to measure the amount of
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activated RhoA compared to total RhoA. Sodium fluoride up-regulated RhoA activity (P < 
0.01) in comparison to the control group. The level of RhoA activity significantly decreased 
with treatment of β-catenin siRNA (P < 0.001) (Figure 7B).
Figure 7: Activity of RhoA with Treatment of β-catenin-siRNA. (A) Western blot
showing activated RhoA and total RhoA. (Lane C, control; lane F, NaF; lane F + si-C, NaF + 
control siRNA; lane F + si-S, NaF + β-catenin-siRNA). (B) Normalized band intensity of
activated RhoA. RhoA activity increased with treatment of sodium fluoride in comparison to 
control group. RhoA activity decreased with β-catenin-siRNA treatment in comparison to 
sodium fluoride treated group (*P < 0.01, **P < 0.001).
In cells treated with β-catenin-siRNA prior to treatment with sodium fluoride, the
Wnt pathway, and presumably β-catenin expression, will be down-regulated. A significant
recovery is seen in ALP activity for NaF + β-catenin-siRNA treated cells. This result was
statistically significant (P < 0.05) in comparison to all other treatment groups (Figure 8).
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Figure 8: Alkaline Phosphatase Activity of β-catenin Inhibited Groups. Cells treated 
with NaF + β-catenin-siRNA showed a significant increase (P < 0.05) in ALP activity
compared to all other treatment groups. (C = Control; F = NaF; F + si-C = NaF + control
siRNA; F + si-S = NaF + β-catenin-siRNA).
3.3 Inhibition of the Rho Pathway Leads to an Increase in Wnt Signaling
Verification of the efficiency of Rho pathway inhibitors, RhoADN plasmid and Y­
27632, was carried out by measuring the activity of both RhoA and ROCK through Western 
blot analysis. As expected, RhoADN plasmid caused a decrease in RhoA activity and 
inhibition with Y-27632 led to a decrease in ROCK activity. Both were statistically
significant (P < 0.05) (Figure 9B). These results confirm the efficiency of the Rho pathway
inhibitors.  
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Figure 9: RhoA and ROCK Activities are Down-regulated by Treatment with RhoADN 
and Y-27632. (A) Western blot showing activated and total RhoA and ROCK. (Lane C, 
control; lane F, NaF; lane FV, NaF + pcDNA3; lane FR, NaF + RhoADN; lane FY, NaF + Y­
27632). (B) Normalized band intensity of activated RhoA and ROCK. Significant decreases 
were seen in RhoA activity with addition of RhoADN plasmid and in ROCK activity with the
addition of Y-27632 (P < 0.05), in comparison to the sodium fluoride treated group.
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Transfection of Rho pathway inhibitors RhoADN plasmid and Y-27632 show an 
increase in Topflash luciferase activity compared to control groups (Figure 10). Groups
treated with NaF and NaF + pcDNA3 maintained a similar value for Topflash luciferase 
activity. However, the NaF + RhoADN and NaF + Y-27632 groups showed significant
increases (P < 0.05) in Topflash luciferase activity and therefore an up-regulation of the Wnt
pathway.
Figure 10: Topflash Activity for Rho and ROCK Inhibited Groups. Both RhoADN and Y­
27632 treated groups had significantly higher luciferase activity (P < 0.05) in comparison to 
the NaF treated group. (C = Control; F = NaF; FV = NaF + pDNA3; FR = NaF + RhoADN; 
FY = NaF + Y-27632)
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Western blot incubated with β-catenin antibody confirmed the results of the Topflash 
assay (Figure 11). The level of β-catenin activity increased significantly after addition of
RhoADN and Y-27632 (both P < 0.001) in comparison to all other treatment groups.
Figure 11: Activity of β-catenin with Treatment of Rho Pathway Inhibitors, RhoADN 
and Y-27632. (A) Western Blot showing β-catenin and GAPDH levels. (Lane C, control;
lane F, NaF; lane FV, NaF + pcDNA3; lane FR, NaF + RhoADN; lane FY, NaF + Y-27632). 
(B) Normalized band intensity of β-catenin. Treatment with sodium fluoride and Rho 
inhibitors RhoADN and Y-27632 caused a significant increase in β-catenin activity (P < 
0.001) compared to all other treatment groups. 
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After 60 hours, ALC treated with 1.5 mM NaF showed a decrease in ALP activity
(Figure 12). A statistically significant decrease in APL activity was observed in groups
treated with NaF + RhoADN and NaF + Y-27632 (P < 0.05) in comparison to all other
treatment groups except each other. 
Figure 12: Alkaline Phosphatase Activity of Rho Inhibited Groups. RhoADN and Y­
27632 treated cells show a significant decrease (P < 0.05) in ALP activity in comparison 
to all other treatment groups except each other. (C = Control; F = NaF; FV = NaF + 
pDNA3; FR = NaF + RhoADN; FY = NaF + Y-27632)
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Discussion
4.1 Summary of Major findings
The major findings of this research were as follows:
1.	 Sodium fluoride activates the Wnt and Rho pathways via conventional Wnt cellular
receptors LRP 5/6 and Frizzled.
2.	 RhoA and ROCK are located downstream of Wnt as confirmed by treatment with 
Wnt pathway cell receptor inhibitors, Dkk-1 and sFRP-2, causing a decrease in RhoA
and ROCK activity.
3.	 Inhibition of the Rho pathway up-regulates Wnt pathway activity.
Previous in vivo studies done with RhoADN transgenic mice containing a dominant
negative N19 mutation, which expresses decreased RhoA activity (Qiu et al., 1995), 
concluded that interference with RhoA expression leads to surface defects in enamel (Li et 
al., 2011). Because the defects seen in RhoADN transgenic mice were somewhat similar to 
those seen in cases of enamel fluorosis, in the present study I looked at ameloblast-lineage 
cells in vitro to determine if the cultured cells are responding through cell signaling
pathways. The main focus of this study was to find out how sodium fluoride affects the
crosstalk between Wnt and Rho in ameloblast cells leading to alterations in pathway
component expression.
In previous studies, ameloblast-lineage cells were treated with fluoride concentrations
varying from 1 to 5 mM (Duan et al., 2011) for time intervals between 30 minutes and 48 
hours (Duan et al., 2011; Li et al., 2011). As part of the present study, I conducted a
preliminary experiment to test five concentrations of fluoride on ameloblast-lineage cells: 1 
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µM, 10 µM, 1 mM, 5 mM, and 10 mM. Fluoride treatment in micromolar concentrations
were too small to cause any detectable change in signaling, and treatment with 5 mM and 10 
mM had a toxic effect on cells. It is difficult to compare the dose of fluoride in drinking
water to the amount in treatment medium since the level of fluoride in drinking water is
significantly lower than the level used in cell culture. Since in vivo ameloblast cells are 
attached to enamel where fluoride can accumulate, their local environment can have very
high concentrations. In order to obtain results within a time period of 4-60 hours, the
concentration of sodium fluoride in the treatment medium was increased to 1.5 mM (28.8 
ppm F). 
The specific inhibitors used in this study were chosen by their efficiency in previous
experiments. Dikkopf related protein-1 and secreted Frizzled related protein-2 have been 
used in multiple studies to down-regulate Wnt signaling and β-catenin through the inhibition 
of LRP5/6 and Frizzled (Liu et al, 2011; Oshima et al., 2005). Two options for inhibition of
β-catenin have been described: β-catenin-siRNA and Quercetin. Based on a literature review, 
siRNA was more commonly used in ameloblast treatment (Duan et al., 2011; Otsu et al., 
2010) and was determined to work efficiently. Lastly, RhoADN plasmid, which decreases
intracellular RhoA activity, and Y-27632, a conventional inhibitor of ROCK, have been 
proven to inhibit RhoA and ROCK in ameloblasts (Ishizaki et al., 2000; Qiu et al., 1995). 
There are multiple ways to analyze cell signaling pathways, but in this study I used various in 
vitro assays to confirm results. The assays used measure different aspects of the pathways to 
avoid false results. 
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4.2 Wnt Cell Receptor Inhibitors Decrease Rho Activity
Since activation of Wnt signaling uncouples the inhibition complex allowing an 
accumulation of β-catenin in the cytoplasm (Liu and Millar, 2010), a decrease in 
cytoplasmic-β-catenin after addition of Wnt pathway cell receptor inhibitors was expected. 
Although the sFRP-2 group showed higher levels of cytoplasmic-β-catenin than the groups
treated with Dkk-1 or both inhibitors, an overall decrease in cytoplasmic-β-catenin 
accumulation was seen when the Wnt pathway was down-regulated. This verifies the
effectiveness of the Wnt cell receptor inhibitors. The results for nuclear-β-catenin did not
seem to follow this trend. A decrease in all three inhibited groups (Dkk-1, sFRP-2 and both 
inhibitors) was expected; however, the only significant result was seen when both inhibitors
were added together. This result could be caused by a translocation of accumulated β-catenin 
to the nucleus prior to the addition of inhibitors and collection of samples. It is apparent that
nuclear-β-catenin was not significantly influenced by either inhibitor when used alone;
however, when used together the inhibitors proved to be efficient. 
These experiments illustrate that 1.5 mM sodium fluoride increases RhoA activity
within 4 hours. The treatment of ameloblast cells with sodium fluoride leads to a change in 
cellular activities through the inactivation of RhoGAP, which activates RhoA (Vincent et al., 
1998; Li et al., 2005). The addition of Wnt cell receptor antagonists Dkk-1 and sFRP-2 to 
cultured ALC causes a decrease of RhoA activity, signifying that RhoA may be downstream 
of Wnt pathway β-catenin. The results of the RhoA activity assay help to explain how ROCK
(measured by phosphorylated MYPT-1) is affected by Dkk-1 and sFRP-2. Again, an increase
in activated ROCK was seen after treatment with sodium fluoride. The Wnt pathway
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inhibitors cause a decrease in activated ROCK, thus further confirming that RhoA and its
effector ROCK are downstream from the Wnt pathway. When the Wnt pathway is blocked, 
the Rho pathway is down-regulated. 
4.3 Intracellular β-catenin Inhibitors Decrease RhoA Activity and Increase ALP Activity
The second group of results showed the effect of β-catenin-siRNA on β-catenin 
transcriptional activity, RhoA activity and alkaline phosphatase (ALP) activity. β-catenin­
siRNA efficiency was verified by down-regulation of β-catenin target expression in the
nucleus using a Topflash Gene Report Assay. Treatment with β-catenin-siRNA led to a
decrease in RhoA activity, again validating that Wnt and β-catenin are located upstream from
RhoA. And lastly, treatment of β-catenin-siRNA caused a significant restoration of ALP
activity. This indicates that when the Wnt pathway is blocked, ALP activity increases. Since 
alkaline phosphatase activity is associated with cell differentiation (O’Gorman et al., 2011), 
high alkaline phosphatase activity in this case implies that the Wnt pathway may negatively
regulate ALC differentiation. This is an expected result because Wnt signaling may act to 
restrict terminal differentiation in ameloblasts, and essentially arrest cells in a state of
proliferation (Lohi, Tucker, and Sharpe, 2010).
4.4 Rho Intracellular Inhibitors Increase Wnt Activity and Decrease ALP activity
Cells treated with Rho pathway inhibitors RhoADN and Y-27632 were used to observe
RhoA and ROCK activity, β-catenin transcription expression, and β-catenin and alkaline
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phosphatase activities. As expected, RhoADN plasmid caused a decrease in RhoA activity and 
inhibition with Y-27632 led to a decrease in ROCK activity. However, treatment with
RhoADN plasmid in the presence of sodium fluoride did not cause a significant decrease in 
ROCK activity, implying that sodium fluoride may up-regulate ROCK activity through a
pathway independent of Rho.
Blocking the Rho pathway may lead to an increase in Wnt pathway activity due to a 
higher amount of signaling. Otsu et al. (2010) discovered that by blocking ROCK with Y­
27632, β-catenin was able to translocate from the cell membrane to the nucleus. ALC treated 
with NaF, NaF + RhoADN, and NaF + Y-27632 and analyzed via Topflash Gene Report
Assay showed an increase in Wnt pathway activity and possible up-regulation of the Wnt
pathway. In addition to the Topflash results, Western blot incubated with β-catenin antibody
further confirmed the up-regulation of β-catenin when the Rho pathway components RhoA
and ROCK were inhibited.
It is clear from previous experiments that treatment with sodium fluoride up-regulates
the Wnt pathway, as do inhibitors of the Rho pathway. Treatment with both of these up-
regulating factors presumably caused an increase in Wnt signaling, which led to a decrease in 
alkaline phosphatase activity. It is also possible that sodium fluoride can influence the
differentiation process of ALC as discussed by Risken et al. (2011), who confirmed that high 
concentrations of fluoride cause a reduction in ALP activity. In addition, Milan, Waddington, 
and Embery (2001) validated that 0.09 M (378 ppm) fluoride inhibits ALP activity. 
Furthermore, previous studies have found a direct relationship between high ALP activity of
ameloblasts and increased enamel mineralization (Gomez, 1994); thus, Wnt signaling may
negatively regulate enamel mineralization.
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4.5 Clinical Relevance
The present study focused on sodium fluoride induced crosstalk between Wnt and 
Rho pathways to better understand the developmental mechanisms of enamel and enamel
fluorosis. It is possible that the development of enamel fluorosis can occur through the
crosstalk of these pathways since both Wnt and Rho pathways have increased activity when 
ALC are treated with sodium fluoride. This is a fairly new topic of discussion in research and 
is particularly important given that exposure to fluoride is available through water, food, and 
other commonly used sources previously mentioned. Although the amount of fluoride
ingested can be theoretically measured, there is a lack of knowledge in respect to the exact
amount of fluoride that reaches the surface of ameloblasts. RhoA has been previously
discovered to have a significant role in the development of enamel and high levels of Wnt
signaling may lead to decreased enamel mineralization. These signaling pathways are 
involved in the development of many oral diseases (Liu and Millar, 2010); therefore, it is
important to thoroughly understand how they function. 
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